Cited by 53

Initial Information on a Novel Nicotine Product

Plurphanswat, Nantaporn, Hughes, John R., Fagerström, Karl, Rodu, Brad·2020·The American Journal on Addictions

Abstract

Background and Objectives: This is the first study to assess the appeal and interest among adults in a new consumer tobacco product, ZYN. We also describe ZYN users, patterns of use, and reasons for use. Methods: Two data sets, consisting of a ZYN‐naive consumer panel (n = 5179) and ZYN users (n = 1266), were provided by Swedish Match North America. Descriptive, cross‐sectional analyses and logistic regression assessed the perceptions of and likelihood of buying ZYN in the consumer panel and the characteristics of ZYN users. Results: The majority of current smokeless tobacco (ST) users in the consumer panel found that ZYN was moderately‐extremely appealing, while never and former tobacco users indicated much less interest; the former were more likely to buy ZYN than other groups. The highest percentage of ZYN users were former tobacco users (43%); very few were never users (4%). The most popular reason for using ZYN was “Less harmful to my health than other tobacco products,” followed by “ease of use.” Discussion and Conclusions: Nonusers of tobacco had very little interest in ZYN. ST users are not only more interested and likely to buy ZYN than other tobacco users, they were the largest group of regular users. Scientific Significance: The first assessment of a new nicotine product, ZYN, suggests that current and former tobacco users may perceive ZYN as a reduced‐risk product. ZYN potentially could be used as a smoking/tobacco‐cessation aid based on reasons of current users. (Am J Addict 2020;00:00–00)

Integrity signals

Registry

Crossref · 10.1111/ajad.13020

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Plurphanswat, N., Hughes, J. R., Fagerström, K., & Rodu, B.
Affiliations
  • James Graham Brown Cancer Center University of Louisville Louisville Kentucky
  • Department of Psychiatry, Center for Behavior and Health University of Vermont Burlington Vermont
  • Fagerström Consulting Vaxholm Sweden
Venue
The American Journal on Addictions
Publisher
Wiley
Published
2020-03-16
Volume
29
Issue
4
Pages
279-286
ISSN
  • 1055-0496
  • 1521-0391
Cited by
53
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review